Get the tools used by (smart)2 investors.

Net Income to Stockholders Margin for Arrowhead Pharmaceuticals Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

ARWR: Arrowhead Pharmaceuticals Inc

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company’s product pipeline includes Plozasiran, which has completed Phase 3 clini...

15.36 USD
Price
USD
Fair Value
Upside
14.22 - 30.41
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Arrowhead Pharmaceuticals Inc's Net Income to Stockholders Margin:

Sep 2016Sep 2018Sep 2020Sep 2022Sep 2024-60,000.0%-40,000.0%-20,000.0%0.0%

Performance Summary
  • Arrowhead Pharmaceuticals's latest twelve months net income to stockholders margin is -25,588.6%
  • Arrowhead Pharmaceuticals's net income to stockholders margin for fiscal years ending September 2020 to 2024 averaged -3,447.6%.
  • Arrowhead Pharmaceuticals's operated at median net income to stockholders margin of -96.1% from fiscal years ending September 2020 to 2024.
  • Looking back at the last 5 years, Arrowhead Pharmaceuticals's net income to stockholders margin peaked in September 2022 at -72.4%.
  • Arrowhead Pharmaceuticals's net income to stockholders margin hit its 5-year low in September 2024 of -16,882.4%.
  • Arrowhead Pharmaceuticals's net income to stockholders margin decreased in 2020 (-96.1%, -338.6%), 2021 (-101.9%, +6.0%), 2023 (-85.3%, +17.8%), and 2024 (-16,882.4%, +19,698.7%) and increased in 2022 (-72.4%, -28.9%).

Benchmarks

Metric Usage: Net Income to Stockholders Margin

Hide this widget
ni_margin
Slug
number
Datatype
text
Format
current
Default Period
FY, Q, LTM, YTD
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Net Income to Stockholders Margin in the efficiency category include:

  • Avg EBITDA Margin (10y) - Ten-year quarterly average EBITDA margin.
  • Payout Ratio - A ratio that measures the percentage of net income a firm is paying out to shareholders versus retaining for reinvestment in the business.
  • Avg EBIT Margin (5y) - Five-year quarterly average EBIT margin.
  • Income Tax Expense Margin - A ratio that measures the GAAP taxes applicable to the earnings after all expenses have been deducted by the business as a percent of revenue.
View Full List

Search for metric or datapoint

Net Income to Stockholders Margin

A ratio that measures the amount of profit that stockholders earn on each dollar of revenue earned by the firm.

Definition of Net Income to Stockholders Margin

Hide this widget

The net income to stockholders margin measures a company’s net income to stockholders as a percentage of the revenue. The formula to calculate net income to stockholders margin and an example calculation for Arrowhead Pharmaceuticals’s trailing twelve months is outlined below:

Net Income to Stockholders Margin  = Net Income to Stockholders / Total Revenue
−25,588.6% = -639.7 M  /  2.5 M

The tables below summarizes Arrowhead Pharmaceuticals’s performance over the last five years:

Fiscal YearNet Income to StockholdersRevenueMargin
2020-09-30-84.553 M87.992 M−96.1%
2021-09-30-140.8 M138.3 M−101.9%
2022-09-30-176.1 M243.2 M−72.4%
2023-09-30-205.3 M240.7 M−85.3%
2024-09-30-599.5 M3.551 M−16,882.4%

The tables below summarizes Arrowhead Pharmaceuticals’s performance over the last four quarters:

Quarter EndingNet Income to StockholdersRevenueMargin
2024-03-31-125.3 MzeroNA
2024-06-30-170.8 MzeroNA
2024-09-30-170.5 MzeroNA
2024-12-31-173.1 M2.5 M−6,923.4%

You can read more about Net Income to Stockholders here.


Click the link below to download a spreadsheet with an example Net Income to Stockholders Margin calculation for Arrowhead Pharmaceuticals Inc below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-44,433.3%-29,433.3%-14,433.3%1,033.3%2006001,000

The chart above depicts the distribution of net income to stockholders margin for companies operating in the Healthcare sector in the Developed economic region. Over 2,010 companies were considered in this analysis, and 1,931 had meaningful values. The average net income to stockholders margin of companies in the sector is -1,135.0% with a standard deviation of 4,278.9%.

Arrowhead Pharmaceuticals Inc's Net Income to Stockholders Margin of -25,588.6% ranks in the 2.5% percentile for the sector. The following table provides additional summary stats:

Net Income to Stockholders Margin In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,011
Included Constituents1,931
Min-45,635.8%
Max105.1%
Median-25.9%
Mean-1,135.0%
Standard Deviation4,278.9%

You can find companies with similar net income to stockholders margin using this stock screener.

All rights reserved. Terms Of Use